data_2eyz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eyz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.775 0.321 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.68 -167.49 0.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.58 63.43 3.72 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.587 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 5' ' ' PHE . 9.9 p-10 -164.88 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.622 0.248 . . . . 0.0 110.914 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 16.5 p90 49.72 174.6 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.608 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -157.43 -168.65 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.816 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.53 -68.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.234 0.54 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -132.01 -88.72 0.45 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.31 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 10' ' ' ARG . 3.8 pt-20 48.34 -69.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.79 0.436 . . . . 0.0 112.15 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -93.03 51.01 1.61 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.4 . . . . 0.0 110.947 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.59 -72.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.674 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.2 p -158.7 -146.14 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.484 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.548 ' CZ3' HD11 ' A' ' 101' ' ' LEU . 64.7 p-90 -71.88 139.63 48.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.904 0.383 . . . . 0.0 110.683 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.9 OUTLIER 176.41 -33.51 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.934 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.594 ' CH2' ' O ' ' A' ' 119' ' ' SER . 88.1 m95 59.16 164.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.177 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 18' ' ' LEU . . . -102.48 169.36 19.39 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.927 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 86.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.785 0.326 . . . . 0.0 111.357 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -68.51 112.09 5.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.842 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.6 t -39.73 -66.13 0.33 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.808 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.27 -41.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.444 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.507 ' HA ' ' CG1' ' A' ' 24' ' ' VAL . 0.6 OUTLIER -81.47 -39.29 25.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.224 0.535 . . . . 0.0 109.835 179.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.527 ' CB ' ' HB2' ' A' ' 122' ' ' ARG . 10.1 mp0 -44.6 -61.03 1.71 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.512 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.429 ' N ' ' HG ' ' A' ' 18' ' ' LEU . . . -64.01 -18.87 64.73 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.507 ' CG1' ' HA ' ' A' ' 21' ' ' GLN . 4.3 p -100.98 -48.48 11.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.131 0.491 . . . . 0.0 111.106 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 21' ' ' GLN . . . -64.23 -45.2 89.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.938 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.485 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -67.81 -25.05 65.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.137 -178.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' CD2' ' HB3' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -100.87 -4.04 28.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.558 ' O ' ' N ' ' A' ' 30' ' ' GLN . 5.2 mt-30 -59.17 -120.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.91 -0.132 . . . . 0.0 111.156 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.02 59.0 0.01 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.821 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 28' ' ' GLN . 18.7 mm-40 -95.82 -166.27 1.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.492 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -51.74 171.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 111.139 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.532 ' O ' ' CG2' ' A' ' 112' ' ' THR . 0.3 OUTLIER -63.06 -18.66 63.61 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.907 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.506 ' CA ' HG23 ' A' ' 115' ' ' ILE . . . -144.64 118.15 1.11 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.492 HG23 ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -159.86 145.72 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.288 0.544 . . . . 0.0 112.311 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 4.3 p90 -141.45 159.39 42.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.764 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -150.22 151.69 33.44 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.508 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 15' ' ' TRP . 13.1 t -121.46 104.55 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.31 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.459 ' HG2' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -100.79 167.37 10.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 46' ' ' ASP . 0.6 OUTLIER -107.6 93.74 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.729 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.424 ' N ' ' HB3' ' A' ' 46' ' ' ASP . 86.9 p -166.04 61.61 0.1 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.056 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.31 171.26 14.31 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.028 0.442 . . . . 0.0 111.609 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -66.77 -176.05 0.46 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.182 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.549 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.8 OUTLIER 78.59 -175.74 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.795 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 89.8 Cg_endo -74.89 -31.4 6.43 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.574 1.516 . . . . 0.0 111.019 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.432 ' O ' ' CZ ' ' A' ' 47' ' ' TYR . . . -116.6 153.78 17.2 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.254 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.483 ' CB ' ' HA ' ' A' ' 39' ' ' ASP . 72.7 m-20 -87.04 137.22 32.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.764 0.316 . . . . 0.0 111.018 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.451 ' CB ' HG21 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -145.11 111.07 5.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.655 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -145.79 163.76 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.472 ' N ' ' CG2' ' A' ' 48' ' ' VAL . 3.4 tm? -152.1 105.2 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.786 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -96.24 135.44 38.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.462 ' CG2' ' CD1' ' A' ' 49' ' ' LEU . 96.6 t -129.94 135.06 61.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.813 0.339 . . . . 0.0 111.311 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.71 166.25 13.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.505 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -169.79 -59.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.576 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.57 -57.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.669 0.271 . . . . 0.0 111.4 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -105.85 104.65 14.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.955 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 55' ' ' SER . 4.2 ptt85 49.3 167.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.781 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 58' ' ' SER . 6.7 t -75.8 161.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.019 0.438 . . . . 0.0 111.225 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.409 ' N ' HG13 ' A' ' 57' ' ' VAL . 5.9 t -118.88 88.71 2.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.107 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 7.2 p-80 -69.99 130.78 43.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.055 0.455 . . . . 0.0 110.154 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.434 ' HB3' HG13 ' A' ' 89' ' ' ILE . 34.6 m-85 -112.21 148.32 34.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.39 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 tt -91.39 136.28 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.366 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.459 HG23 ' HG ' ' A' ' 87' ' ' LEU . 23.4 mt -134.85 147.58 29.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.213 0.53 . . . . 0.0 111.108 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.54 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 24.9 t30 -116.07 155.44 28.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.911 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 14.0 t -178.24 168.01 1.92 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.062 0.458 . . . . 0.0 111.823 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.401 ' N ' ' HB3' ' A' ' 85' ' ' SER . 0.2 OUTLIER -161.33 177.46 10.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.894 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -73.14 -46.52 27.37 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.994 -0.548 . . . . 0.0 114.136 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 66' ' ' GLY . 1.5 Cg_endo -42.91 167.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.945 2.43 . . . . 0.0 113.394 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.532 ' HG2' ' HD3' ' A' ' 70' ' ' PRO . 12.5 ttm-85 -72.35 126.32 91.05 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.995 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.55 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 42.9 Cg_endo -102.1 27.18 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.323 2.682 . . . . 0.0 115.278 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 69' ' ' PRO . 74.0 Cg_exo -47.57 -65.32 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.677 1.585 . . . . 0.0 112.377 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.73 149.99 67.14 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.819 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.51 108.25 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.535 2.157 . . . . 0.0 112.229 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -95.87 -166.78 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.142 2.562 . . . . 0.0 112.427 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.419 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 1.6 m -130.36 52.96 10.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 74' ' ' SER . 87.4 Cg_endo -81.59 -167.27 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.89 -73.76 0.67 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.066 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -155.28 127.08 3.78 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.177 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.414 ' HB3' ' HG3' ' A' ' 67' ' ' PRO . 31.2 Cg_exo -59.66 147.81 90.36 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.481 2.12 . . . . 0.0 112.11 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.471 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 32.5 Cg_exo -59.27 -48.56 13.36 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.254 1.969 . . . . 0.0 112.537 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 79' ' ' PRO . 96.4 Cg_endo -86.04 -44.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.618 2.212 . . . . 0.0 113.073 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.569 ' HA2' ' HG3' ' A' ' 44' ' ' PRO . . . -70.86 -168.77 8.18 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.073 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.795 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 87.6 t -105.55 -17.12 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 116.771 0.286 . . . . 0.0 111.464 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.409 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER 174.42 166.88 0.33 Allowed Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.738 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 3.1 Cg_exo -40.43 123.5 1.52 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.084 2.523 . . . . 0.0 112.287 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ARG . 12.0 p -54.3 -109.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.733 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 61.59 135.26 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.583 HD22 ' HA ' ' A' ' 97' ' ' LEU . 3.0 mp -90.27 163.31 14.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.19 0.519 . . . . 0.0 111.634 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.581 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 0.7 OUTLIER -140.44 165.61 26.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.599 -179.018 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 88' ' ' ARG . 14.8 tt 148.85 137.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 123.703 0.627 . . . . 0.0 110.852 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 35.24 62.52 0.6 Allowed Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.398 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 48.0 29.01 1.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.899 0.38 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.56 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -118.51 170.39 8.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.327 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 92' ' ' GLN . 5.4 mt-10 -159.26 114.9 2.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.861 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.433 ' HE1' ' CG2' ' A' ' 89' ' ' ILE . 31.4 m-85 -99.39 -113.82 0.17 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.679 0.276 . . . . 0.0 110.617 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -168.53 -35.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.953 0.406 . . . . 0.0 110.15 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.43 ' CB ' ' HB3' ' A' ' 295' ' ' ASP . 1.0 OUTLIER -134.13 152.68 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.719 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.583 ' HA ' HD22 ' A' ' 87' ' ' LEU . 2.1 mm? -61.08 -59.51 13.55 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.7 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 97' ' ' LEU . 11.3 Cg_endo -55.18 -30.16 69.82 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.728 1.619 . . . . 0.0 110.76 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.405 ' CB ' ' OG ' ' A' ' 96' ' ' SER . . . -70.08 -31.83 69.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.491 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' A' ' 103' ' ' PHE . 8.7 tt -74.54 -59.94 2.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.529 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.548 HD11 ' CZ3' ' A' ' 13' ' ' TRP . 4.0 mt -52.51 -21.12 3.44 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 10.9 mt-10 -80.25 44.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.246 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -96.95 -28.62 14.1 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -76.62 -11.64 59.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.528 ' HD2' ' HB3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -69.53 -18.14 63.64 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.646 0.26 . . . . 0.0 110.741 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.474 HG12 ' H ' ' A' ' 107' ' ' HIS . 0.0 OUTLIER -107.66 -60.2 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.513 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.474 ' H ' HG12 ' A' ' 106' ' ' ILE . 21.3 m-70 -166.22 104.73 0.65 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.7 p90 43.46 -169.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.76 ' HG ' HG12 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -145.01 -177.65 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.845 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.08 -58.03 1.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.754 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.549 ' O ' HD23 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -135.07 120.83 19.55 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 32' ' ' HIS . 19.3 p 99.04 -172.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.292 1.037 . . . . 0.0 110.263 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.18 111.13 16.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.251 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 104' ' ' TYR . 2.2 mm? 60.01 93.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.455 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.76 HG12 ' HG ' ' A' ' 109' ' ' LEU . 26.5 pt -97.15 173.53 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.018 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' NE1' ' A' ' 169' ' ' TRP . 2.8 pt-20 -161.35 156.9 21.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.512 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -46.51 139.96 12.5 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.295 1.997 . . . . 0.0 111.184 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -70.31 170.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.594 ' O ' ' CH2' ' A' ' 15' ' ' TRP . 56.1 p -61.66 -145.79 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.74 -67.4 0.85 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' A' ' 122' ' ' ARG . 0.2 OUTLIER 46.94 -153.74 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.539 177.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.59 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER 45.54 21.33 0.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.161 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 65.22 89.93 0.09 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.788 0.328 . . . . 0.0 110.562 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.27 156.76 21.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.806 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 79.5 p -106.14 -9.01 17.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -117.8 136.11 12.21 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.893 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.13 138.46 52.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.808 0.337 . . . . 0.0 111.131 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 tp -76.27 142.16 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.526 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 129' ' ' LEU . 1.7 pt? -165.31 58.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 152.08 25.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.578 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.04 43.32 1.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.531 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -81.59 153.2 26.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.24 -176.92 5.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 112.6 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.95 -151.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.764 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.91 157.26 20.91 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -91.14 160.15 15.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.73 0.776 . . . . 0.0 112.168 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -124.3 163.53 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.889 -178.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.482 ' N ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -122.06 144.66 48.78 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.42 ' N ' ' HG2' ' A' ' 138' ' ' ARG . . . -77.6 138.45 39.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.98 5.28 26.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.616 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -147.87 169.11 20.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 111.514 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.77 161.45 23.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.504 ' CA ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -94.38 143.45 26.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.935 -178.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 169.01 135.69 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.772 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -168.35 -137.66 2.29 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.942 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.423 ' CB ' ' HA ' ' A' ' 31' ' ' ARG . 16.0 t-20 -156.33 -42.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.779 0.323 . . . . 0.0 111.233 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.409 ' HB2' ' HD2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -72.89 132.4 43.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.001 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -76.23 -28.09 57.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 0.1 OUTLIER -58.96 -43.37 91.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.884 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.35 178.31 6.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.358 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.509 ' HB2' ' HA3' ' A' ' 180' ' ' GLY . 0.2 OUTLIER -131.03 110.44 15.53 Favored Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.738 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.32 146.07 63.5 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.92 1.747 . . . . 0.0 110.178 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.533 ' CE2' ' HG3' ' A' ' 183' ' ' PRO . 9.1 p90 -110.76 132.05 54.53 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.583 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 4.8 mtmt -105.26 124.77 50.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.697 0.284 . . . . 0.0 110.34 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -38.8 136.33 0.76 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.68 -2.62 30.79 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.746 -0.661 . . . . 0.0 114.254 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -85.6 132.07 34.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.462 0.631 . . . . 0.0 111.596 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 15.7 mm -90.2 128.11 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.588 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 mt -119.62 139.04 52.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.543 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.8 135.04 40.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.789 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 39.1 mm -71.86 145.01 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.163 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.77 -14.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.168 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.82 157.93 0.11 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.729 0.3 . . . . 0.0 110.682 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 170' ' ' TRP . 13.5 mmtp -113.15 94.31 29.89 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.637 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -85.33 -14.23 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.778 2.319 . . . . 0.0 113.067 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -140.83 178.9 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.139 0.495 . . . . 0.0 111.359 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 224' ' ' PRO . 5.0 mm-40 -93.1 -13.66 28.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.195 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.426 ' C ' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -129.59 7.8 5.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.35 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.432 ' NE1' ' CB ' ' A' ' 116' ' ' GLU . 53.5 m95 -148.29 123.06 9.92 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.427 ' CD2' ' HE2' ' A' ' 164' ' ' LYS . 12.7 m0 -107.2 156.83 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.076 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 181' ' ' MET . 32.2 m-20 -89.03 127.21 35.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 111.484 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.28 158.09 43.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.448 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -98.39 151.23 20.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.99 170.08 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.765 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.3 t -70.11 3.8 2.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.009 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -108.02 -11.68 15.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.607 0.242 . . . . 0.0 111.146 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 111.26 -24.82 15.04 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.674 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -62.56 145.36 54.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.501 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -113.11 155.51 24.81 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.019 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.509 ' HA3' ' HB2' ' A' ' 151' ' ' LEU . . . 169.59 -156.22 26.99 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.163 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 171' ' ' ASN . 2.3 ptt? -121.32 142.76 49.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.313 0.578 . . . . 0.0 112.239 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 169' ' ' TRP . 17.9 pt -113.9 157.08 42.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.216 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.533 ' HG3' ' CE2' ' A' ' 153' ' ' PHE . 73.8 Cg_endo -75.29 151.32 38.09 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.505 2.137 . . . . 0.0 113.549 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.435 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 6.6 t -82.78 -48.66 0.81 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.515 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 61.5 Cg_endo -87.77 29.09 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.692 2.262 . . . . 0.0 113.412 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -132.58 -13.86 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.441 ' CG2' HG22 ' A' ' 137' ' ' VAL . 15.6 m -116.78 170.78 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.759 0.314 . . . . 0.0 111.165 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.48 126.32 52.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.858 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.17 118.5 11.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.63 133.51 55.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.0 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.37 105.34 46.55 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.007 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.78 -78.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.347 2.031 . . . . 0.0 112.633 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -174.99 -47.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 111.109 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 22.6 p -85.18 79.26 9.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -140.65 -39.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.43 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.5 m -111.1 85.62 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.0 110.745 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.18 -45.21 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.088 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.74 -167.0 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.062 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -88.72 -77.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 tp -177.18 -59.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.997 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.6 mt 68.62 -68.17 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.72 -170.33 54.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.599 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -126.06 -171.07 13.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -146.43 -58.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 110.942 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.07 92.27 2.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -126.81 -178.39 4.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -174.52 -45.61 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.483 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 65.5 p -118.87 165.5 13.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.82 112.92 17.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.78 171.65 13.01 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.444 2.096 . . . . 0.0 112.299 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -90.53 155.69 45.88 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.96 64.03 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.598 2.198 . . . . 0.0 112.322 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.47 162.77 13.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 81.48 -58.96 4.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 115.76 133.06 5.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.422 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.49 159.13 54.78 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.629 2.219 . . . . 0.0 112.073 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -73.45 147.38 87.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.03 135.53 63.36 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.582 2.188 . . . . 0.0 112.111 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 157.26 -152.92 24.23 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.532 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.97 -29.26 57.59 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 123.006 2.47 . . . . 0.0 112.157 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -70.13 -29.49 66.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.883 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -161.55 104.21 1.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -114.93 149.7 42.9 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.987 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' A' ' 167' ' ' GLU . 73.6 Cg_exo -52.31 -168.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.251 2.634 . . . . 0.0 113.496 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.445 ' HB2' ' CE ' ' A' ' 105' ' ' LYS . 59.7 p -54.46 84.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.166 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.404 HG12 ' CG1' ' A' ' 184' ' ' VAL . 15.5 m -107.17 -35.84 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.145 0.498 . . . . 0.0 110.13 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -129.79 6.98 5.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.967 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -108.09 105.26 56.07 Favored Pre-proline 0 C--O 1.231 0.125 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.517 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.431 ' O ' ' CD ' ' A' ' 105' ' ' LYS . 13.7 Cg_exo -69.62 -35.94 12.11 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.632 2.222 . . . . 0.0 111.989 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.672 ' HB3' ' CD ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -120.61 -67.53 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.297 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.672 ' CD ' ' HB3' ' A' ' 230' ' ' LEU . 3.1 Cg_exo -45.14 138.61 9.25 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.306 2.004 . . . . 0.0 112.633 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -87.47 172.68 9.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.399 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 233' ' ' LEU . 1.7 pt? -174.73 42.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.81 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -51.17 -46.83 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.336 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -130.9 -20.24 2.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.662 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 237' ' ' PRO . . . 135.24 108.16 0.95 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.817 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 233' ' ' LEU . 59.4 Cg_exo -52.68 -162.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.863 2.375 . . . . 0.0 112.415 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.548 ' HB ' ' HD3' ' A' ' 292' ' ' ARG . 27.3 mm -84.54 109.6 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.545 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.596 ' HA ' HD23 ' A' ' 263' ' ' LEU . 44.1 m-85 -127.27 103.78 7.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.436 . . . . 0.0 111.225 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 263' ' ' LEU . . . -163.48 -96.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.843 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.464 ' HG3' ' HA2' ' A' ' 261' ' ' GLY . 0.4 OUTLIER -137.29 134.69 36.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.924 -0.126 . . . . 0.0 111.156 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 260' ' ' VAL . 45.7 t -48.23 140.29 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 291' ' ' VAL . 0.2 OUTLIER -85.91 -29.99 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.458 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 2.4 tp-100 -135.08 150.2 50.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.676 0.274 . . . . 0.0 111.189 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 19.9 tttm -92.54 118.78 31.35 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.598 ' HB2' ' CG ' ' A' ' 290' ' ' HIS . 0.2 OUTLIER -133.45 106.72 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.472 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.21 163.02 41.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.29 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -85.35 157.25 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.077 2.518 . . . . 0.0 112.03 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.432 ' HB3' ' CE2' ' A' ' 251' ' ' TYR . 19.9 m-80 -67.63 152.45 45.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.183 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.86 74.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.189 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 249' ' ' ASN . 37.8 p90 -79.52 -3.47 46.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.642 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.51 171.22 15.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.706 0.289 . . . . 0.0 110.751 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 -68.83 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.085 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.2 t -91.29 27.85 1.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -83.36 157.79 22.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.118 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 277' ' ' GLY . 1.1 mt -101.0 141.36 34.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -98.32 105.81 18.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.813 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.467 ' CD1' ' CG1' ' A' ' 291' ' ' VAL . 0.5 OUTLIER -100.04 128.64 46.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.815 -177.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 8.4 pt-20 -141.27 128.91 21.5 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.159 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.494 ' HA ' ' HB ' ' A' ' 242' ' ' VAL . 0.9 OUTLIER -48.84 114.07 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-O 121.433 0.635 . . . . 0.0 110.939 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.464 ' HA2' ' HG3' ' A' ' 241' ' ' ARG . . . 146.96 -59.41 0.48 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.326 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.61 176.82 1.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.087 0.47 . . . . 0.0 111.725 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 239' ' ' TYR . 2.4 tm? -117.58 126.72 53.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.352 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 278' ' ' GLU . 7.9 p -126.88 140.07 50.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.051 0.453 . . . . 0.0 111.456 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.529 ' O ' ' HA2' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -102.25 152.1 21.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 294' ' ' LEU . 25.3 t -85.53 85.11 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.474 ' H ' ' HA2' ' A' ' 277' ' ' GLY . 0.3 OUTLIER -96.1 106.89 19.13 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.224 0.535 . . . . 0.0 111.332 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.538 ' HB3' ' HG2' ' A' ' 276' ' ' GLU . 2.8 mptp? 83.77 100.99 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.538 ' CG2' ' CE2' ' A' ' 275' ' ' TRP . 59.7 mt -105.98 114.86 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.23 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.743 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 0.6 OUTLIER -80.83 171.69 14.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.504 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.6 p -74.79 -48.17 34.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.3 t -79.08 30.21 0.21 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 91.04 -34.55 4.22 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.619 -1.276 . . . . 0.0 115.929 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.743 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -76.09 103.78 6.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.473 1.137 . . . . 0.0 111.55 -177.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.606 ' HB2' ' CE2' ' A' ' 288' ' ' PHE . 6.0 m0 -111.62 169.74 8.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.647 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -118.43 147.56 43.46 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.524 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.585 ' O ' HD12 ' A' ' 256' ' ' LEU . . . -133.22 175.42 20.14 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.745 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.472 ' CB ' ' HD3' ' A' ' 265' ' ' LYS . 0.6 OUTLIER -112.8 110.87 21.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.954 0.406 . . . . 0.0 110.744 178.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 1.6 t -127.28 118.84 24.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.292 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.3 34.41 20.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.97 1.0 71.47 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.47 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.63 140.6 30.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 110.761 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.431 ' CG ' ' HG3' ' A' ' 278' ' ' GLU . 22.9 mtp85 -119.48 115.68 24.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.218 0.533 . . . . 0.0 110.946 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.52 ' H ' ' CD1' ' A' ' 256' ' ' LEU . . . -156.27 170.98 33.97 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.47 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -99.92 117.01 33.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -114.21 156.12 44.67 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.431 ' HG2' ' HG3' ' A' ' 246' ' ' ARG . 1.5 Cg_endo -42.71 -31.35 2.02 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.562 2.174 . . . . 0.0 111.516 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.606 ' CE2' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER 67.97 4.26 3.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.027 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 33.5 p -83.68 -8.66 59.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 110.176 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.598 ' CG ' ' HB2' ' A' ' 246' ' ' ARG . 3.1 m80 -105.01 9.22 34.53 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.463 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.545 ' CG2' ' CD1' ' A' ' 288' ' ' PHE . 23.4 m -129.63 156.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.778 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.548 ' HD3' ' HB ' ' A' ' 238' ' ' ILE . 0.1 OUTLIER -82.84 104.88 13.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.187 0.518 . . . . 0.0 110.373 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.49 HD11 ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -57.79 174.54 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.28 -178.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -135.25 156.63 48.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.196 178.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 294' ' ' LEU . 1.3 m-20 164.3 -81.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.245 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.17 52.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.94 0.4 . . . . 0.0 110.847 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.81 114.13 24.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -128.07 126.16 23.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.67 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.74 -52.5 5.28 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.905 2.403 . . . . 0.0 112.796 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.92 23.12 6.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.459 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -46.65 -51.02 16.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.365 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.98 22.95 8.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 304' ' ' SER . 43.0 p90 -52.79 -39.2 62.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.084 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' SER . . . . . 0.404 ' HB2' ' CD2' ' A' ' 303' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.961 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.775 0.321 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.68 -167.49 0.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.58 63.43 3.72 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.587 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 5' ' ' PHE . 9.9 p-10 -164.88 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.622 0.248 . . . . 0.0 110.914 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 16.5 p90 49.72 174.6 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.608 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -157.43 -168.65 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.816 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.53 -68.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.234 0.54 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -132.01 -88.72 0.45 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.31 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 10' ' ' ARG . 3.8 pt-20 48.34 -69.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.79 0.436 . . . . 0.0 112.15 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -93.03 51.01 1.61 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.4 . . . . 0.0 110.947 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.59 -72.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.674 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 165' ' ' PRO . 36.2 p -158.7 -146.14 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.554 ' CZ3' HD11 ' A' ' 101' ' ' LEU . 64.7 p-90 -71.88 139.63 48.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.904 0.383 . . . . 0.0 110.683 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.9 OUTLIER 176.41 -33.51 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.934 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.637 ' CH2' HD13 ' A' ' 26' ' ' LEU . 88.1 m95 59.16 164.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.177 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 18' ' ' LEU . . . -102.48 169.36 19.39 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.927 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 86.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.785 0.326 . . . . 0.0 111.357 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.505 HD12 ' CB ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -68.51 112.09 5.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.842 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.6 t -39.73 -66.13 0.33 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.808 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -170.27 -41.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.444 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.516 ' HA ' ' CG1' ' A' ' 24' ' ' VAL . 0.6 OUTLIER -81.47 -39.29 25.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.224 0.535 . . . . 0.0 109.835 179.336 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.715 ' O ' HD23 ' A' ' 26' ' ' LEU . 10.1 mp0 -44.6 -61.03 1.71 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.512 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.667 ' HA ' HD11 ' A' ' 36' ' ' LEU . . . -64.01 -18.87 64.73 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 21' ' ' GLN . 4.3 p -100.98 -48.48 11.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.131 0.491 . . . . 0.0 111.106 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' A' ' 28' ' ' GLN . . . -64.23 -45.2 89.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.938 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -67.81 -25.05 65.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.137 -178.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.824 HD23 HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -100.87 -4.04 28.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.558 ' O ' ' N ' ' A' ' 30' ' ' GLN . 5.2 mt-30 -59.17 -120.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.91 -0.132 . . . . 0.0 111.156 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.02 59.0 0.01 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.821 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.563 ' CB ' HG21 ' A' ' 34' ' ' VAL . 18.7 mm-40 -95.82 -166.27 1.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.497 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -51.74 171.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 111.139 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.555 ' O ' HG21 ' A' ' 112' ' ' THR . 0.3 OUTLIER -63.06 -18.66 63.61 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.907 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.562 ' CA ' HG22 ' A' ' 115' ' ' ILE . . . -144.64 118.15 1.11 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.589 ' HB ' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -159.86 145.72 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.288 0.544 . . . . 0.0 112.311 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.996 ' HB3' HD12 ' A' ' 115' ' ' ILE . 4.3 p90 -141.45 159.39 42.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.764 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.883 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -150.22 151.69 33.44 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.508 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 15' ' ' TRP . 13.1 t -121.46 104.55 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.31 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.526 ' HG2' HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -100.79 167.37 10.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 46' ' ' ASP . 0.6 OUTLIER -107.6 93.74 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.729 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.43 ' N ' ' HB3' ' A' ' 46' ' ' ASP . 86.9 p -166.04 61.61 0.1 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.056 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.31 171.26 14.31 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.028 0.442 . . . . 0.0 111.609 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -66.77 -176.05 0.46 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.182 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.573 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.8 OUTLIER 78.59 -175.74 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.821 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 89.8 Cg_endo -74.89 -31.4 6.43 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.574 1.516 . . . . 0.0 111.019 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.432 ' O ' ' CZ ' ' A' ' 47' ' ' TYR . . . -116.6 153.78 17.2 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.254 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.492 ' CB ' ' HA ' ' A' ' 39' ' ' ASP . 72.7 m-20 -87.04 137.22 32.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.764 0.316 . . . . 0.0 111.018 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CZ ' ' O ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -145.11 111.07 5.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.655 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.526 HG11 ' HG2' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -145.79 163.76 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.631 ' CD1' HG23 ' A' ' 51' ' ' VAL . 3.4 tm? -152.1 105.2 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.786 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -96.24 135.44 38.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.631 HG23 ' CD1' ' A' ' 49' ' ' LEU . 96.6 t -129.94 135.06 61.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.813 0.339 . . . . 0.0 111.311 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.567 ' HB3' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -89.71 166.25 13.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.505 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.692 ' OE1' HG21 ' A' ' 111' ' ' THR . 3.1 pt-20 -169.79 -59.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.576 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -160.57 -57.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.669 0.271 . . . . 0.0 111.4 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -105.85 104.65 14.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.955 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 55' ' ' SER . 4.2 ptt85 49.3 167.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.781 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 58' ' ' SER . 6.7 t -75.8 161.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.019 0.438 . . . . 0.0 111.225 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.527 ' N ' HG12 ' A' ' 57' ' ' VAL . 5.9 t -118.88 88.71 2.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.107 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 21.1 p80 -69.99 130.78 43.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.055 0.455 . . . . 0.0 110.154 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.442 ' CD1' HG13 ' A' ' 89' ' ' ILE . 34.6 m-85 -112.21 148.32 34.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.39 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 tt -91.39 136.28 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.366 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.664 HG23 ' HG ' ' A' ' 87' ' ' LEU . 23.4 mt -134.85 147.58 29.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.213 0.53 . . . . 0.0 111.108 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 24.9 t30 -116.07 155.44 28.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.911 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 14.0 t -178.24 168.01 1.92 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.062 0.458 . . . . 0.0 111.823 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.421 ' N ' ' HB3' ' A' ' 85' ' ' SER . 0.2 OUTLIER -161.33 177.46 10.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.894 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.661 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -73.14 -46.52 27.37 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.994 -0.548 . . . . 0.0 114.136 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 66' ' ' GLY . 1.5 Cg_endo -42.91 167.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.945 2.43 . . . . 0.0 113.394 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG2' ' HD3' ' A' ' 70' ' ' PRO . 12.5 ttm-85 -72.35 126.32 91.05 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.995 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.55 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 42.9 Cg_endo -102.1 27.18 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.323 2.682 . . . . 0.0 115.278 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 69' ' ' PRO . 74.0 Cg_exo -47.57 -65.32 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.677 1.585 . . . . 0.0 112.377 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.904 HG12 ' HA3' ' A' ' 273' ' ' GLY . 34.7 m -125.73 149.99 67.14 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.819 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.51 108.25 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.535 2.157 . . . . 0.0 112.229 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -95.87 -166.78 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.142 2.562 . . . . 0.0 112.427 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.44 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 1.6 m -130.36 52.96 10.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 74' ' ' SER . 87.4 Cg_endo -81.59 -167.27 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.89 -73.76 0.67 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.066 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 2.5 tt0 -155.28 127.08 3.78 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.177 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.436 ' HD2' ' CA ' ' A' ' 83' ' ' SER . 31.2 Cg_exo -59.66 147.81 90.36 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.481 2.12 . . . . 0.0 112.11 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.465 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 32.5 Cg_exo -59.27 -48.56 13.36 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.254 1.969 . . . . 0.0 112.537 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 79' ' ' PRO . 96.4 Cg_endo -86.04 -44.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.618 2.212 . . . . 0.0 113.073 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.593 ' HA2' ' HG3' ' A' ' 44' ' ' PRO . . . -70.86 -168.77 8.18 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.073 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.821 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 87.6 t -105.55 -17.12 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 116.771 0.286 . . . . 0.0 111.464 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.436 ' CA ' ' HD2' ' A' ' 78' ' ' PRO . 0.1 OUTLIER 174.42 166.88 0.33 Allowed Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.738 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 3.1 Cg_exo -40.43 123.5 1.52 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.084 2.523 . . . . 0.0 112.287 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ARG . 12.0 p -54.3 -109.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.733 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 61.59 135.26 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.71 HD21 HD22 ' A' ' 97' ' ' LEU . 3.0 mp -90.27 163.31 14.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.19 0.519 . . . . 0.0 111.634 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.571 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 0.7 OUTLIER -140.44 165.61 26.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.599 -179.018 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 100' ' ' LEU . 14.8 tt 148.85 137.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 123.703 0.627 . . . . 0.0 110.852 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 35.24 62.52 0.6 Allowed Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.398 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 48.0 29.01 1.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.899 0.38 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.563 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -118.51 170.39 8.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.327 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 92' ' ' GLN . 5.4 mt-10 -159.26 114.9 2.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.861 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.72 ' CD1' HD12 ' A' ' 100' ' ' LEU . 31.4 m-85 -99.39 -113.82 0.17 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.679 0.276 . . . . 0.0 110.617 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -168.53 -35.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.953 0.406 . . . . 0.0 110.15 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.606 ' O ' HD22 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -134.13 152.68 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.719 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.71 HD22 HD21 ' A' ' 87' ' ' LEU . 2.1 mm? -61.08 -59.51 13.55 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.7 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 97' ' ' LEU . 11.3 Cg_endo -55.18 -30.16 69.82 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.728 1.619 . . . . 0.0 110.76 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 230' ' ' LEU . . . -70.08 -31.83 69.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.491 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.72 HD12 ' CD1' ' A' ' 94' ' ' PHE . 8.7 tt -74.54 -59.94 2.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.529 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.554 HD11 ' CZ3' ' A' ' 13' ' ' TRP . 4.0 mt -52.51 -21.12 3.44 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.536 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 10.9 mt-10 -80.25 44.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.246 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.698 ' CE1' HD11 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -96.95 -28.62 14.1 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.623 ' HB2' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -76.62 -11.64 59.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.536 ' HD2' ' HB3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -69.53 -18.14 63.64 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.646 0.26 . . . . 0.0 110.741 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.516 ' N ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -107.66 -60.2 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.513 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.453 ' H ' HG12 ' A' ' 106' ' ' ILE . 7.5 m80 -166.22 104.73 0.65 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.7 p90 43.46 -169.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.76 ' HG ' HG12 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -145.01 -177.65 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.845 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.08 -58.03 1.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.754 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.692 HG21 ' OE1' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -135.07 120.83 19.55 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.555 HG21 ' O ' ' A' ' 32' ' ' HIS . 19.3 p 99.04 -172.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.292 1.037 . . . . 0.0 110.263 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.18 111.13 16.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.251 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.645 ' N ' HD22 ' A' ' 114' ' ' LEU . 2.2 mm? 60.01 93.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.455 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.996 HD12 ' HB3' ' A' ' 35' ' ' PHE . 26.5 pt -97.15 173.53 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.018 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' NE1' ' A' ' 169' ' ' TRP . 2.8 pt-20 -161.35 156.9 21.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.512 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.6 ' HA ' ' O ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -46.51 139.96 12.5 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.295 1.997 . . . . 0.0 111.184 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.59 HG21 HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.31 170.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.594 ' O ' ' CH2' ' A' ' 15' ' ' TRP . 56.1 p -61.66 -145.79 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.74 -67.4 0.85 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.482 ' O ' ' HD3' ' A' ' 122' ' ' ARG . 0.2 OUTLIER 46.94 -153.74 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.539 177.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.603 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER 45.54 21.33 0.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.161 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 65.22 89.93 0.09 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.788 0.328 . . . . 0.0 110.562 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.27 156.76 21.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.806 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 79.5 p -106.14 -9.01 17.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -117.8 136.11 12.21 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.893 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.13 138.46 52.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.808 0.337 . . . . 0.0 111.131 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 tp -76.27 142.16 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.526 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.638 HD23 ' N ' ' A' ' 129' ' ' LEU . 1.7 pt? -165.31 58.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 152.08 25.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.578 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.04 43.32 1.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.531 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -81.59 153.2 26.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.24 -176.92 5.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 112.6 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.95 -151.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.764 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.42 ' HB2' ' HD2' ' A' ' 192' ' ' PRO . 0.6 OUTLIER -84.91 157.26 20.91 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -91.14 160.15 15.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.73 0.776 . . . . 0.0 112.168 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -124.3 163.53 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.889 -178.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.622 ' HG3' HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -122.06 144.66 48.78 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.804 ' HA ' HG12 ' A' ' 187' ' ' VAL . . . -77.6 138.45 39.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.98 5.28 26.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.616 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -147.87 169.11 20.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 111.514 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.77 161.45 23.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.504 ' CA ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -94.38 143.45 26.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.935 -178.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 169.01 135.69 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.772 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -168.35 -137.66 2.29 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.942 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 31' ' ' ARG . 16.0 t-20 -156.33 -42.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.779 0.323 . . . . 0.0 111.233 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -72.89 132.4 43.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.001 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -76.23 -28.09 57.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 0.1 OUTLIER -58.96 -43.37 91.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.884 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.415 ' HB3' ' CE ' ' A' ' 181' ' ' MET . 2.8 p30 -76.35 178.31 6.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.358 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.739 HD23 ' C ' ' A' ' 179' ' ' ARG . 0.2 OUTLIER -131.03 110.44 15.53 Favored Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.738 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.32 146.07 63.5 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.92 1.747 . . . . 0.0 110.178 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.546 ' CE2' ' HG3' ' A' ' 183' ' ' PRO . 9.1 p90 -110.76 132.05 54.53 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.583 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 4.8 mtmt -105.26 124.77 50.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.697 0.284 . . . . 0.0 110.34 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -38.8 136.33 0.76 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.68 -2.62 30.79 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.746 -0.661 . . . . 0.0 114.254 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -85.6 132.07 34.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.462 0.631 . . . . 0.0 111.596 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.622 HD13 ' HG3' ' A' ' 138' ' ' ARG . 15.7 mm -90.2 128.11 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.588 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.728 HD13 HG21 ' A' ' 182' ' ' ILE . 1.2 mt -119.62 139.04 52.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.543 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.8 135.04 40.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.789 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 39.1 mm -71.86 145.01 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.163 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.77 -14.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.168 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.82 157.93 0.11 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.729 0.3 . . . . 0.0 110.682 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.427 ' HD3' ' CG ' ' A' ' 170' ' ' TRP . 13.5 mmtp -113.15 94.31 29.89 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.637 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' SER . 86.8 Cg_endo -85.33 -14.23 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.778 2.319 . . . . 0.0 113.067 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -140.83 178.9 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.139 0.495 . . . . 0.0 111.359 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 224' ' ' PRO . 5.0 mm-40 -93.1 -13.66 28.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.195 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.426 ' C ' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -129.59 7.8 5.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.35 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.432 ' NE1' ' CB ' ' A' ' 116' ' ' GLU . 53.5 m95 -148.29 123.06 9.92 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.555 ' CE2' HG22 ' A' ' 184' ' ' VAL . 12.7 m0 -107.2 156.83 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.076 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 181' ' ' MET . 32.2 m-20 -89.03 127.21 35.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 111.484 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.536 ' HB1' ' HB3' ' A' ' 159' ' ' LEU . . . -148.28 158.09 43.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.448 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.64 ' O ' HD23 ' A' ' 159' ' ' LEU . 8.8 tt0 -98.39 151.23 20.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.625 ' HB2' HD11 ' A' ' 151' ' ' LEU . 10.5 t70 -95.99 170.08 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.765 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.3 t -70.11 3.8 2.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.009 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -108.02 -11.68 15.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.607 0.242 . . . . 0.0 111.146 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 111.26 -24.82 15.04 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.674 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -62.56 145.36 54.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.501 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.739 ' C ' HD23 ' A' ' 151' ' ' LEU . 31.5 mmt180 -113.11 155.51 24.81 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 151' ' ' LEU . . . 169.59 -156.22 26.99 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.163 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 171' ' ' ASN . 2.3 ptt? -121.32 142.76 49.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.313 0.578 . . . . 0.0 112.239 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.728 HG21 HD13 ' A' ' 159' ' ' LEU . 17.9 pt -113.9 157.08 42.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.216 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.546 ' HG3' ' CE2' ' A' ' 153' ' ' PHE . 73.8 Cg_endo -75.29 151.32 38.09 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.505 2.137 . . . . 0.0 113.549 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.738 HG11 ' O ' ' A' ' 225' ' ' SER . 6.6 t -82.78 -48.66 0.81 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.515 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.455 ' HD3' ' HB ' ' A' ' 184' ' ' VAL . 61.5 Cg_endo -87.77 29.09 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.692 2.262 . . . . 0.0 113.412 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.411 ' HB2' ' CG ' ' A' ' 183' ' ' PRO . 1.3 m-85 -132.58 -13.86 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 139' ' ' ALA . 15.6 m -116.78 170.78 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.759 0.314 . . . . 0.0 111.165 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.48 126.32 52.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.858 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.17 118.5 11.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.63 133.51 55.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.0 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.37 105.34 46.55 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.007 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 135' ' ' GLU . 49.2 Cg_endo -74.78 -78.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.347 2.031 . . . . 0.0 112.633 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -174.99 -47.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 111.109 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 22.6 p -85.18 79.26 9.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -140.65 -39.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.43 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.5 m -111.1 85.62 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.0 110.745 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.18 -45.21 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.088 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.74 -167.0 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.062 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -88.72 -77.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 tp -177.18 -59.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.997 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.6 mt 68.62 -68.17 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.72 -170.33 54.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.599 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -126.06 -171.07 13.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -146.43 -58.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 110.942 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.07 92.27 2.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -126.81 -178.39 4.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -174.52 -45.61 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.483 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 65.5 p -118.87 165.5 13.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.82 112.92 17.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.78 171.65 13.01 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.444 2.096 . . . . 0.0 112.299 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.481 ' HB2' HD23 ' A' ' 213' ' ' LEU . 87.6 mm-40 -90.53 155.69 45.88 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.96 64.03 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.598 2.198 . . . . 0.0 112.322 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 211' ' ' GLN . 3.9 mm? -96.47 162.77 13.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 81.48 -58.96 4.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 115.76 133.06 5.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.422 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.49 159.13 54.78 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.629 2.219 . . . . 0.0 112.073 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -73.45 147.38 87.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.03 135.53 63.36 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.582 2.188 . . . . 0.0 112.111 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 157.26 -152.92 24.23 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.532 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.97 -29.26 57.59 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 123.006 2.47 . . . . 0.0 112.157 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -70.13 -29.49 66.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.883 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -161.55 104.21 1.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.444 ' HG3' HG21 ' A' ' 226' ' ' VAL . 0.2 OUTLIER -114.93 149.7 42.9 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.987 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.486 ' HB3' ' HA ' ' A' ' 167' ' ' GLU . 73.6 Cg_exo -52.31 -168.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.251 2.634 . . . . 0.0 113.496 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.738 ' O ' HG11 ' A' ' 184' ' ' VAL . 59.7 p -54.46 84.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.166 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.614 HG12 HG13 ' A' ' 184' ' ' VAL . 15.5 m -107.17 -35.84 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.145 0.498 . . . . 0.0 110.13 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.79 6.98 5.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.967 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.714 HG22 ' HG2' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -108.09 105.26 56.07 Favored Pre-proline 0 C--O 1.231 0.125 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.517 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.431 ' O ' ' CD ' ' A' ' 105' ' ' LYS . 13.7 Cg_exo -69.62 -35.94 12.11 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.632 2.222 . . . . 0.0 111.989 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.688 ' HB3' ' CD ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -120.61 -67.53 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.297 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.714 ' HG2' HG22 ' A' ' 228' ' ' THR . 3.1 Cg_exo -45.14 138.61 9.25 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.306 2.004 . . . . 0.0 112.633 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.434 ' ND2' ' OE2' ' A' ' 167' ' ' GLU . 1.6 t-20 -87.47 172.68 9.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.399 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 233' ' ' LEU . 1.7 pt? -174.73 42.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.81 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -51.17 -46.83 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.336 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -130.9 -20.24 2.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.662 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 237' ' ' PRO . . . 135.24 108.16 0.95 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.817 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 233' ' ' LEU . 59.4 Cg_exo -52.68 -162.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.863 2.375 . . . . 0.0 112.415 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.637 HG21 ' HG2' ' A' ' 292' ' ' ARG . 27.3 mm -84.54 109.6 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.545 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.432 ' HA ' HD21 ' A' ' 263' ' ' LEU . 44.1 m-85 -127.27 103.78 7.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.436 . . . . 0.0 111.225 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.569 ' H ' HD23 ' A' ' 263' ' ' LEU . . . -163.48 -96.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.843 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.493 ' HG3' ' HA2' ' A' ' 261' ' ' GLY . 0.4 OUTLIER -137.29 134.69 36.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.924 -0.126 . . . . 0.0 111.156 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 258' ' ' LEU . 45.7 t -48.23 140.29 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 290' ' ' HIS . 0.2 OUTLIER -85.91 -29.99 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.486 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 2.4 tp-100 -135.08 150.2 50.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.676 0.274 . . . . 0.0 111.189 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.884 ' HB2' HG12 ' A' ' 260' ' ' VAL . 19.9 tttm -92.54 118.78 31.35 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.6 ' HB2' ' CG ' ' A' ' 290' ' ' HIS . 0.2 OUTLIER -133.45 106.72 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.472 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.21 163.02 41.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.29 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -85.35 157.25 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.077 2.518 . . . . 0.0 112.03 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.429 ' HB3' ' CE2' ' A' ' 251' ' ' TYR . 19.9 m-80 -67.63 152.45 45.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.183 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.86 74.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.189 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 249' ' ' ASN . 37.8 p90 -79.52 -3.47 46.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.642 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.51 171.22 15.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.706 0.289 . . . . 0.0 110.751 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 -68.83 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.085 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.2 t -91.29 27.85 1.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -83.36 157.79 22.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.118 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.6 HD12 ' H ' ' A' ' 284' ' ' GLY . 1.1 mt -101.0 141.36 34.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -98.32 105.81 18.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.813 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.752 HD11 HG12 ' A' ' 291' ' ' VAL . 0.5 OUTLIER -100.04 128.64 46.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.815 -177.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 8.4 pt-20 -141.27 128.91 21.5 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.159 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.884 HG12 ' HB2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -48.84 114.07 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-O 121.433 0.635 . . . . 0.0 110.939 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.493 ' HA2' ' HG3' ' A' ' 241' ' ' ARG . . . 146.96 -59.41 0.48 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.326 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.61 176.82 1.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.087 0.47 . . . . 0.0 111.725 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 264' ' ' VAL . 2.4 tm? -117.58 126.72 53.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.352 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.636 HG21 ' CZ ' ' A' ' 286' ' ' PHE . 7.9 p -126.88 140.07 50.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.051 0.453 . . . . 0.0 111.456 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.557 ' O ' ' HA2' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -102.25 152.1 21.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 1.088 HG21 HD12 ' A' ' 294' ' ' LEU . 25.3 t -85.53 85.11 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.555 HG22 ' HA2' ' A' ' 277' ' ' GLY . 0.3 OUTLIER -96.1 106.89 19.13 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.224 0.535 . . . . 0.0 111.332 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.59 ' HB3' ' HG2' ' A' ' 276' ' ' GLU . 2.8 mptp? 83.77 100.99 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.952 HG23 ' CE2' ' A' ' 275' ' ' TRP . 59.7 mt -105.98 114.86 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.23 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.768 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 0.6 OUTLIER -80.83 171.69 14.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.504 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 272' ' ' SER . 14.6 p -74.79 -48.17 34.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.518 ' N ' HG13 ' A' ' 271' ' ' VAL . 5.3 t -79.08 30.21 0.21 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -176.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.904 ' HA3' HG12 ' A' ' 71' ' ' VAL . . . 91.04 -34.55 4.22 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.619 -1.276 . . . . 0.0 115.929 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.768 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -76.09 103.78 6.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.473 1.137 . . . . 0.0 111.55 -177.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.952 ' CE2' HG23 ' A' ' 269' ' ' ILE . 6.0 m0 -111.62 169.74 8.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.647 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -118.43 147.56 43.46 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.524 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 265' ' ' LYS . . . -133.22 175.42 20.14 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.745 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.486 ' CB ' ' HD3' ' A' ' 265' ' ' LYS . 0.6 OUTLIER -112.8 110.87 21.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.954 0.406 . . . . 0.0 110.744 178.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 1.6 t -127.28 118.84 24.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.292 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.3 34.41 20.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.97 1.0 71.47 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.47 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.63 140.6 30.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 110.761 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.456 ' CG ' ' HG3' ' A' ' 278' ' ' GLU . 22.9 mtp85 -119.48 115.68 24.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.218 0.533 . . . . 0.0 110.946 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.6 ' H ' HD12 ' A' ' 256' ' ' LEU . . . -156.27 170.98 33.97 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.47 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -99.92 117.01 33.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.636 ' CZ ' HG21 ' A' ' 264' ' ' VAL . 0.1 OUTLIER -114.21 156.12 44.67 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.452 ' HG3' ' NE ' ' A' ' 246' ' ' ARG . 1.5 Cg_endo -42.71 -31.35 2.02 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.562 2.174 . . . . 0.0 111.516 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.762 ' CD1' HG21 ' A' ' 291' ' ' VAL . 0.0 OUTLIER 67.97 4.26 3.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.027 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 33.5 p -83.68 -8.66 59.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 110.176 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.6 ' CG ' ' HB2' ' A' ' 246' ' ' ARG . 3.1 m80 -105.01 9.22 34.53 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.463 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.762 HG21 ' CD1' ' A' ' 288' ' ' PHE . 23.4 m -129.63 156.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.778 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.637 ' HG2' HG21 ' A' ' 238' ' ' ILE . 0.1 OUTLIER -82.84 104.88 13.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.187 0.518 . . . . 0.0 110.373 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.892 HD22 ' N ' ' A' ' 294' ' ' LEU . 0.0 OUTLIER -57.79 174.54 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.28 -178.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 1.088 HD12 HG21 ' A' ' 266' ' ' VAL . 0.0 OUTLIER -135.25 156.63 48.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.196 178.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 294' ' ' LEU . 1.3 m-20 164.3 -81.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.245 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.17 52.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.94 0.4 . . . . 0.0 110.847 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.81 114.13 24.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 301' ' ' GLU . 31.9 t-20 -128.07 126.16 23.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.67 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.74 -52.5 5.28 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.905 2.403 . . . . 0.0 112.796 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.92 23.12 6.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.459 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 298' ' ' ASN . 25.8 tt0 -46.65 -51.02 16.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.365 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.98 22.95 8.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.421 ' CD2' ' HB2' ' A' ' 304' ' ' SER . 43.0 p90 -52.79 -39.2 62.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.084 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' A' ' 303' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.961 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.775 0.321 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.68 -167.49 0.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.58 63.43 3.72 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.587 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 5' ' ' PHE . 9.9 p-10 -164.88 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.622 0.248 . . . . 0.0 110.914 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 16.5 p90 49.72 174.6 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.608 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -157.43 -168.65 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.816 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.53 -68.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.234 0.54 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -132.01 -88.72 0.45 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.31 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 10' ' ' ARG . 3.8 pt-20 48.34 -69.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.79 0.436 . . . . 0.0 112.15 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -93.03 51.01 1.61 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.941 0.4 . . . . 0.0 110.947 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.59 -72.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.674 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 165' ' ' PRO . 36.2 p -158.7 -146.14 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.554 ' CZ3' HD11 ' A' ' 101' ' ' LEU . 64.7 p-90 -71.88 139.63 48.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.904 0.383 . . . . 0.0 110.683 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' O ' ' O ' ' A' ' 37' ' ' VAL . 0.9 OUTLIER 176.41 -33.51 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.934 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.637 ' CH2' HD13 ' A' ' 26' ' ' LEU . 88.1 m95 59.16 164.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.177 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 18' ' ' LEU . . . -102.48 169.36 19.39 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.927 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.04 86.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.785 0.326 . . . . 0.0 111.357 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.505 HD12 ' CB ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -68.51 112.09 5.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.842 179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.6 t -39.73 -66.13 0.33 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.808 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -170.27 -41.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.444 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.516 ' HA ' ' CG1' ' A' ' 24' ' ' VAL . 0.6 OUTLIER -81.47 -39.29 25.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.224 0.535 . . . . 0.0 109.835 179.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.715 ' O ' HD23 ' A' ' 26' ' ' LEU . 10.1 mp0 -44.6 -61.03 1.71 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.512 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.667 ' HA ' HD11 ' A' ' 36' ' ' LEU . . . -64.01 -18.87 64.73 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 21' ' ' GLN . 4.3 p -100.98 -48.48 11.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.131 0.491 . . . . 0.0 111.106 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' A' ' 28' ' ' GLN . . . -64.23 -45.2 89.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.938 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -67.81 -25.05 65.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.137 -178.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.824 HD23 HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -100.87 -4.04 28.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.558 ' O ' ' N ' ' A' ' 30' ' ' GLN . 5.2 mt-30 -59.17 -120.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.91 -0.132 . . . . 0.0 111.156 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.02 59.0 0.01 OUTLIER Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.821 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.563 ' CB ' HG21 ' A' ' 34' ' ' VAL . 18.7 mm-40 -95.82 -166.27 1.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.497 ' HD3' ' CG1' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -51.74 171.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 111.139 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.555 ' O ' HG21 ' A' ' 112' ' ' THR . 0.3 OUTLIER -63.06 -18.66 63.61 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.907 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.562 ' CA ' HG22 ' A' ' 115' ' ' ILE . . . -144.64 118.15 1.11 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.589 ' HB ' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -159.86 145.72 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.288 0.544 . . . . 0.0 112.311 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.996 ' HB3' HD12 ' A' ' 115' ' ' ILE . 4.3 p90 -141.45 159.39 42.31 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.764 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.883 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -150.22 151.69 33.44 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.508 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 15' ' ' TRP . 13.1 t -121.46 104.55 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.31 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.526 ' HG2' HG11 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -100.79 167.37 10.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 46' ' ' ASP . 0.6 OUTLIER -107.6 93.74 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.729 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.43 ' N ' ' HB3' ' A' ' 46' ' ' ASP . 86.9 p -166.04 61.61 0.1 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.056 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.31 171.26 14.31 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.028 0.442 . . . . 0.0 111.609 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -66.77 -176.05 0.46 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.182 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.573 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.8 OUTLIER 78.59 -175.74 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.821 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 89.8 Cg_endo -74.89 -31.4 6.43 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.574 1.516 . . . . 0.0 111.019 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.432 ' O ' ' CZ ' ' A' ' 47' ' ' TYR . . . -116.6 153.78 17.2 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.254 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.492 ' CB ' ' HA ' ' A' ' 39' ' ' ASP . 72.7 m-20 -87.04 137.22 32.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.764 0.316 . . . . 0.0 111.018 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CZ ' ' O ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -145.11 111.07 5.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.655 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.526 HG11 ' HG2' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -145.79 163.76 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.631 ' CD1' HG23 ' A' ' 51' ' ' VAL . 3.4 tm? -152.1 105.2 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.786 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -96.24 135.44 38.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.631 HG23 ' CD1' ' A' ' 49' ' ' LEU . 96.6 t -129.94 135.06 61.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.813 0.339 . . . . 0.0 111.311 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.567 ' HB3' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -89.71 166.25 13.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.505 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.692 ' OE1' HG21 ' A' ' 111' ' ' THR . 3.1 pt-20 -169.79 -59.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.576 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.57 -57.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.669 0.271 . . . . 0.0 111.4 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -105.85 104.65 14.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.955 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 55' ' ' SER . 4.2 ptt85 49.3 167.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.781 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 58' ' ' SER . 6.7 t -75.8 161.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.019 0.438 . . . . 0.0 111.225 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.527 ' N ' HG12 ' A' ' 57' ' ' VAL . 5.9 t -118.88 88.71 2.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.107 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 7.2 p-80 -69.99 130.78 43.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.055 0.455 . . . . 0.0 110.154 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.442 ' CD1' HG13 ' A' ' 89' ' ' ILE . 34.6 m-85 -112.21 148.32 34.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.39 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.6 tt -91.39 136.28 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.366 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.664 HG23 ' HG ' ' A' ' 87' ' ' LEU . 23.4 mt -134.85 147.58 29.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.213 0.53 . . . . 0.0 111.108 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 24.9 t30 -116.07 155.44 28.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.911 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 14.0 t -178.24 168.01 1.92 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.062 0.458 . . . . 0.0 111.823 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.421 ' N ' ' HB3' ' A' ' 85' ' ' SER . 0.2 OUTLIER -161.33 177.46 10.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.894 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.661 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -73.14 -46.52 27.37 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.994 -0.548 . . . . 0.0 114.136 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 66' ' ' GLY . 1.5 Cg_endo -42.91 167.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.945 2.43 . . . . 0.0 113.394 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG2' ' HD3' ' A' ' 70' ' ' PRO . 12.5 ttm-85 -72.35 126.32 91.05 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.995 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.55 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 42.9 Cg_endo -102.1 27.18 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.323 2.682 . . . . 0.0 115.278 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 69' ' ' PRO . 74.0 Cg_exo -47.57 -65.32 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.677 1.585 . . . . 0.0 112.377 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.904 HG12 ' HA3' ' A' ' 273' ' ' GLY . 34.7 m -125.73 149.99 67.14 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.819 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.51 108.25 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.535 2.157 . . . . 0.0 112.229 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -95.87 -166.78 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.142 2.562 . . . . 0.0 112.427 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.44 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 1.6 m -130.36 52.96 10.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 74' ' ' SER . 87.4 Cg_endo -81.59 -167.27 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.89 -73.76 0.67 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.066 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 2.5 tt0 -155.28 127.08 3.78 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.177 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.436 ' HD2' ' CA ' ' A' ' 83' ' ' SER . 31.2 Cg_exo -59.66 147.81 90.36 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.481 2.12 . . . . 0.0 112.11 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.465 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 32.5 Cg_exo -59.27 -48.56 13.36 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.254 1.969 . . . . 0.0 112.537 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 79' ' ' PRO . 96.4 Cg_endo -86.04 -44.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.618 2.212 . . . . 0.0 113.073 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.593 ' HA2' ' HG3' ' A' ' 44' ' ' PRO . . . -70.86 -168.77 8.18 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.073 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.821 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 87.6 t -105.55 -17.12 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 116.771 0.286 . . . . 0.0 111.464 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.436 ' CA ' ' HD2' ' A' ' 78' ' ' PRO . 0.1 OUTLIER 174.42 166.88 0.33 Allowed Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.738 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 83' ' ' SER . 3.1 Cg_exo -40.43 123.5 1.52 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.084 2.523 . . . . 0.0 112.287 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ARG . 12.0 p -54.3 -109.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.733 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 61.59 135.26 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.71 HD21 HD22 ' A' ' 97' ' ' LEU . 3.0 mp -90.27 163.31 14.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.19 0.519 . . . . 0.0 111.634 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.571 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 0.7 OUTLIER -140.44 165.61 26.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.599 -179.018 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 100' ' ' LEU . 14.8 tt 148.85 137.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 123.703 0.627 . . . . 0.0 110.852 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 35.24 62.52 0.6 Allowed Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.398 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 48.0 29.01 1.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.899 0.38 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.563 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -118.51 170.39 8.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.327 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 92' ' ' GLN . 5.4 mt-10 -159.26 114.9 2.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.861 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.72 ' CD1' HD12 ' A' ' 100' ' ' LEU . 31.4 m-85 -99.39 -113.82 0.17 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.679 0.276 . . . . 0.0 110.617 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -168.53 -35.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.953 0.406 . . . . 0.0 110.15 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.606 ' O ' HD22 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -134.13 152.68 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.719 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.71 HD22 HD21 ' A' ' 87' ' ' LEU . 2.1 mm? -61.08 -59.51 13.55 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.7 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 97' ' ' LEU . 11.3 Cg_endo -55.18 -30.16 69.82 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.728 1.619 . . . . 0.0 110.76 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 230' ' ' LEU . . . -70.08 -31.83 69.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.491 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.72 HD12 ' CD1' ' A' ' 94' ' ' PHE . 8.7 tt -74.54 -59.94 2.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.529 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.554 HD11 ' CZ3' ' A' ' 13' ' ' TRP . 4.0 mt -52.51 -21.12 3.44 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.536 ' HB3' ' HD2' ' A' ' 105' ' ' LYS . 10.9 mt-10 -80.25 44.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.246 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.698 ' CE1' HD11 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -96.95 -28.62 14.1 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.623 ' HB2' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -76.62 -11.64 59.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.536 ' HD2' ' HB3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -69.53 -18.14 63.64 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.646 0.26 . . . . 0.0 110.741 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -107.66 -60.2 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.513 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.453 ' H ' HG12 ' A' ' 106' ' ' ILE . 21.3 m-70 -166.22 104.73 0.65 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.7 p90 43.46 -169.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.76 ' HG ' HG12 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -145.01 -177.65 5.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.845 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.08 -58.03 1.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.754 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.692 HG21 ' OE1' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -135.07 120.83 19.55 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.555 HG21 ' O ' ' A' ' 32' ' ' HIS . 19.3 p 99.04 -172.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.292 1.037 . . . . 0.0 110.263 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.18 111.13 16.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.251 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.645 ' N ' HD22 ' A' ' 114' ' ' LEU . 2.2 mm? 60.01 93.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.455 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.996 HD12 ' HB3' ' A' ' 35' ' ' PHE . 26.5 pt -97.15 173.53 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.018 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' NE1' ' A' ' 169' ' ' TRP . 2.8 pt-20 -161.35 156.9 21.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.512 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.6 ' HA ' ' O ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -46.51 139.96 12.5 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.295 1.997 . . . . 0.0 111.184 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.59 HG21 HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.31 170.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.594 ' O ' ' CH2' ' A' ' 15' ' ' TRP . 56.1 p -61.66 -145.79 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.74 -67.4 0.85 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.482 ' O ' ' HD3' ' A' ' 122' ' ' ARG . 0.2 OUTLIER 46.94 -153.74 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.539 177.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER 45.54 21.33 0.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.161 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 65.22 89.93 0.09 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.788 0.328 . . . . 0.0 110.562 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.27 156.76 21.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.806 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 79.5 p -106.14 -9.01 17.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -117.8 136.11 12.21 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.893 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.13 138.46 52.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.808 0.337 . . . . 0.0 111.131 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 tp -76.27 142.16 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.526 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.638 HD23 ' N ' ' A' ' 129' ' ' LEU . 1.7 pt? -165.31 58.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 152.08 25.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.578 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.04 43.32 1.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.531 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -81.59 153.2 26.84 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.24 -176.92 5.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 112.6 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -175.95 -151.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.764 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.42 ' HB2' ' HD2' ' A' ' 192' ' ' PRO . 0.6 OUTLIER -84.91 157.26 20.91 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -91.14 160.15 15.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.73 0.776 . . . . 0.0 112.168 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 138' ' ' ARG . 1.0 OUTLIER -124.3 163.53 24.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.889 -178.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.622 ' HG3' HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -122.06 144.66 48.78 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.804 ' HA ' HG12 ' A' ' 187' ' ' VAL . . . -77.6 138.45 39.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.98 5.28 26.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.616 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -147.87 169.11 20.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 111.514 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.77 161.45 23.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.504 ' CA ' ' O ' ' A' ' 153' ' ' PHE . 0.1 OUTLIER -94.38 143.45 26.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.935 -178.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 169.01 135.69 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.772 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -168.35 -137.66 2.29 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.942 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 31' ' ' ARG . 16.0 t-20 -156.33 -42.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.779 0.323 . . . . 0.0 111.233 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -72.89 132.4 43.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 111.001 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -76.23 -28.09 57.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 0.1 OUTLIER -58.96 -43.37 91.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.884 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.415 ' HB3' ' CE ' ' A' ' 181' ' ' MET . 2.8 p30 -76.35 178.31 6.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.358 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.739 HD23 ' C ' ' A' ' 179' ' ' ARG . 0.2 OUTLIER -131.03 110.44 15.53 Favored Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.738 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.32 146.07 63.5 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.92 1.747 . . . . 0.0 110.178 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.546 ' CE2' ' HG3' ' A' ' 183' ' ' PRO . 9.1 p90 -110.76 132.05 54.53 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.583 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 4.8 mtmt -105.26 124.77 50.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.697 0.284 . . . . 0.0 110.34 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -38.8 136.33 0.76 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.68 -2.62 30.79 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.746 -0.661 . . . . 0.0 114.254 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -85.6 132.07 34.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.462 0.631 . . . . 0.0 111.596 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.622 HD13 ' HG3' ' A' ' 138' ' ' ARG . 15.7 mm -90.2 128.11 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.588 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.728 HD13 HG21 ' A' ' 182' ' ' ILE . 1.2 mt -119.62 139.04 52.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.543 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.8 135.04 40.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.789 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 39.1 mm -71.86 145.01 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.163 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.77 -14.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.168 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.82 157.93 0.11 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.729 0.3 . . . . 0.0 110.682 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.427 ' HD3' ' CG ' ' A' ' 170' ' ' TRP . 13.5 mmtp -113.15 94.31 29.89 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.637 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' SER . 86.8 Cg_endo -85.33 -14.23 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.778 2.319 . . . . 0.0 113.067 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -140.83 178.9 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.139 0.495 . . . . 0.0 111.359 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 224' ' ' PRO . 5.0 mm-40 -93.1 -13.66 28.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.195 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.426 ' C ' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -129.59 7.8 5.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.35 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.432 ' NE1' ' CB ' ' A' ' 116' ' ' GLU . 53.5 m95 -148.29 123.06 9.92 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.555 ' CE2' HG22 ' A' ' 184' ' ' VAL . 12.7 m0 -107.2 156.83 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.076 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 181' ' ' MET . 32.2 m-20 -89.03 127.21 35.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 111.484 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.536 ' HB1' ' HB3' ' A' ' 159' ' ' LEU . . . -148.28 158.09 43.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.448 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.64 ' O ' HD23 ' A' ' 159' ' ' LEU . 8.8 tt0 -98.39 151.23 20.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.625 ' HB2' HD11 ' A' ' 151' ' ' LEU . 10.5 t70 -95.99 170.08 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.765 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.3 t -70.11 3.8 2.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.009 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -108.02 -11.68 15.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.607 0.242 . . . . 0.0 111.146 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 111.26 -24.82 15.04 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.674 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -62.56 145.36 54.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.501 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.739 ' C ' HD23 ' A' ' 151' ' ' LEU . 31.5 mmt180 -113.11 155.51 24.81 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 151' ' ' LEU . . . 169.59 -156.22 26.99 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.163 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 171' ' ' ASN . 2.3 ptt? -121.32 142.76 49.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.313 0.578 . . . . 0.0 112.239 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.728 HG21 HD13 ' A' ' 159' ' ' LEU . 17.9 pt -113.9 157.08 42.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.216 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.546 ' HG3' ' CE2' ' A' ' 153' ' ' PHE . 73.8 Cg_endo -75.29 151.32 38.09 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.505 2.137 . . . . 0.0 113.549 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.738 HG11 ' O ' ' A' ' 225' ' ' SER . 6.6 t -82.78 -48.66 0.81 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.515 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.455 ' HD3' ' HB ' ' A' ' 184' ' ' VAL . 61.5 Cg_endo -87.77 29.09 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.692 2.262 . . . . 0.0 113.412 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.411 ' HB2' ' CG ' ' A' ' 183' ' ' PRO . 1.3 m-85 -132.58 -13.86 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 139' ' ' ALA . 15.6 m -116.78 170.78 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.759 0.314 . . . . 0.0 111.165 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.48 126.32 52.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.858 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.17 118.5 11.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.63 133.51 55.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.0 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.37 105.34 46.55 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.007 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 135' ' ' GLU . 49.2 Cg_endo -74.78 -78.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.347 2.031 . . . . 0.0 112.633 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -174.99 -47.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 111.109 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 22.6 p -85.18 79.26 9.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -140.65 -39.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.43 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.5 m -111.1 85.62 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.0 110.745 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.18 -45.21 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.088 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.74 -167.0 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.062 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -88.72 -77.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 tp -177.18 -59.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.997 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.6 mt 68.62 -68.17 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.72 -170.33 54.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.599 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -126.06 -171.07 13.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -146.43 -58.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 110.942 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.07 92.27 2.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -126.81 -178.39 4.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -174.52 -45.61 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.483 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 65.5 p -118.87 165.5 13.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -72.82 112.92 17.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.78 171.65 13.01 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.444 2.096 . . . . 0.0 112.299 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.481 ' HB2' HD23 ' A' ' 213' ' ' LEU . 87.6 mm-40 -90.53 155.69 45.88 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.96 64.03 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.598 2.198 . . . . 0.0 112.322 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 211' ' ' GLN . 3.9 mm? -96.47 162.77 13.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 81.48 -58.96 4.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 115.76 133.06 5.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.422 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.49 159.13 54.78 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.629 2.219 . . . . 0.0 112.073 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -73.45 147.38 87.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.03 135.53 63.36 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.582 2.188 . . . . 0.0 112.111 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 157.26 -152.92 24.23 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.532 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.97 -29.26 57.59 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 123.006 2.47 . . . . 0.0 112.157 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -70.13 -29.49 66.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.883 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -161.55 104.21 1.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.444 ' HG3' HG21 ' A' ' 226' ' ' VAL . 1.7 pt20 -114.93 149.7 42.9 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.987 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.486 ' HB3' ' HA ' ' A' ' 167' ' ' GLU . 73.6 Cg_exo -52.31 -168.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.251 2.634 . . . . 0.0 113.496 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.738 ' O ' HG11 ' A' ' 184' ' ' VAL . 59.7 p -54.46 84.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.166 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.614 HG12 HG13 ' A' ' 184' ' ' VAL . 15.5 m -107.17 -35.84 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.145 0.498 . . . . 0.0 110.13 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -129.79 6.98 5.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.967 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.714 HG22 ' HG2' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -108.09 105.26 56.07 Favored Pre-proline 0 C--O 1.231 0.125 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.517 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.431 ' O ' ' CD ' ' A' ' 105' ' ' LYS . 13.7 Cg_exo -69.62 -35.94 12.11 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.632 2.222 . . . . 0.0 111.989 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.688 ' HB3' ' CD ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -120.61 -67.53 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.297 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.714 ' HG2' HG22 ' A' ' 228' ' ' THR . 3.1 Cg_exo -45.14 138.61 9.25 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.306 2.004 . . . . 0.0 112.633 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -87.47 172.68 9.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.399 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 233' ' ' LEU . 1.7 pt? -174.73 42.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.81 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -51.17 -46.83 62.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.336 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -130.9 -20.24 2.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.662 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 237' ' ' PRO . . . 135.24 108.16 0.95 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.817 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 233' ' ' LEU . 59.4 Cg_exo -52.68 -162.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.863 2.375 . . . . 0.0 112.415 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.637 HG21 ' HG2' ' A' ' 292' ' ' ARG . 27.3 mm -84.54 109.6 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.545 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.432 ' HA ' HD21 ' A' ' 263' ' ' LEU . 44.1 m-85 -127.27 103.78 7.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.436 . . . . 0.0 111.225 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.569 ' H ' HD23 ' A' ' 263' ' ' LEU . . . -163.48 -96.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.843 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.493 ' HG3' ' HA2' ' A' ' 261' ' ' GLY . 0.4 OUTLIER -137.29 134.69 36.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.924 -0.126 . . . . 0.0 111.156 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.589 HG11 HD13 ' A' ' 258' ' ' LEU . 45.7 t -48.23 140.29 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 290' ' ' HIS . 0.2 OUTLIER -85.91 -29.99 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.486 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 2.4 tp-100 -135.08 150.2 50.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.676 0.274 . . . . 0.0 111.189 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.884 ' HB2' HG12 ' A' ' 260' ' ' VAL . 19.9 tttm -92.54 118.78 31.35 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.6 ' HB2' ' CG ' ' A' ' 290' ' ' HIS . 0.2 OUTLIER -133.45 106.72 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.472 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.21 163.02 41.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.29 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -85.35 157.25 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.077 2.518 . . . . 0.0 112.03 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.429 ' HB3' ' CE2' ' A' ' 251' ' ' TYR . 19.9 m-80 -67.63 152.45 45.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.183 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.86 74.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.189 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 249' ' ' ASN . 37.8 p90 -79.52 -3.47 46.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.642 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.51 171.22 15.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.706 0.289 . . . . 0.0 110.751 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.2 -68.83 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.085 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.2 t -91.29 27.85 1.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -83.36 157.79 22.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.118 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.6 HD12 ' H ' ' A' ' 284' ' ' GLY . 1.1 mt -101.0 141.36 34.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -98.32 105.81 18.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.813 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.752 HD11 HG12 ' A' ' 291' ' ' VAL . 0.5 OUTLIER -100.04 128.64 46.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.815 -177.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 245' ' ' LYS . 8.4 pt-20 -141.27 128.91 21.5 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.159 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.884 HG12 ' HB2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -48.84 114.07 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-O 121.433 0.635 . . . . 0.0 110.939 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.493 ' HA2' ' HG3' ' A' ' 241' ' ' ARG . . . 146.96 -59.41 0.48 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.326 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.61 176.82 1.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.087 0.47 . . . . 0.0 111.725 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 264' ' ' VAL . 2.4 tm? -117.58 126.72 53.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.352 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.636 HG21 ' CZ ' ' A' ' 286' ' ' PHE . 7.9 p -126.88 140.07 50.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.051 0.453 . . . . 0.0 111.456 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.557 ' O ' ' HA2' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -102.25 152.1 21.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 1.088 HG21 HD12 ' A' ' 294' ' ' LEU . 25.3 t -85.53 85.11 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.555 HG22 ' HA2' ' A' ' 277' ' ' GLY . 0.3 OUTLIER -96.1 106.89 19.13 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.224 0.535 . . . . 0.0 111.332 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.59 ' HB3' ' HG2' ' A' ' 276' ' ' GLU . 2.8 mptp? 83.77 100.99 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.952 HG23 ' CE2' ' A' ' 275' ' ' TRP . 59.7 mt -105.98 114.86 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.23 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.768 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 0.6 OUTLIER -80.83 171.69 14.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.504 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 272' ' ' SER . 14.6 p -74.79 -48.17 34.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.518 ' N ' HG13 ' A' ' 271' ' ' VAL . 5.3 t -79.08 30.21 0.21 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -176.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.904 ' HA3' HG12 ' A' ' 71' ' ' VAL . . . 91.04 -34.55 4.22 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.619 -1.276 . . . . 0.0 115.929 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.768 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -76.09 103.78 6.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.473 1.137 . . . . 0.0 111.55 -177.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.952 ' CE2' HG23 ' A' ' 269' ' ' ILE . 6.0 m0 -111.62 169.74 8.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.647 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -118.43 147.56 43.46 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.524 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 265' ' ' LYS . . . -133.22 175.42 20.14 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.745 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.486 ' CB ' ' HD3' ' A' ' 265' ' ' LYS . 0.6 OUTLIER -112.8 110.87 21.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.954 0.406 . . . . 0.0 110.744 178.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 1.6 t -127.28 118.84 24.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.292 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.3 34.41 20.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.97 1.0 71.47 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.47 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.63 140.6 30.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 110.761 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.456 ' CG ' ' HG3' ' A' ' 278' ' ' GLU . 22.9 mtp85 -119.48 115.68 24.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.218 0.533 . . . . 0.0 110.946 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.6 ' H ' HD12 ' A' ' 256' ' ' LEU . . . -156.27 170.98 33.97 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.47 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -99.92 117.01 33.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.636 ' CZ ' HG21 ' A' ' 264' ' ' VAL . 0.1 OUTLIER -114.21 156.12 44.67 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.452 ' HG3' ' NE ' ' A' ' 246' ' ' ARG . 1.5 Cg_endo -42.71 -31.35 2.02 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.562 2.174 . . . . 0.0 111.516 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.762 ' CD1' HG21 ' A' ' 291' ' ' VAL . 0.0 OUTLIER 67.97 4.26 3.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.027 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 33.5 p -83.68 -8.66 59.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 110.176 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.6 ' CG ' ' HB2' ' A' ' 246' ' ' ARG . 3.1 m80 -105.01 9.22 34.53 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.463 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.762 HG21 ' CD1' ' A' ' 288' ' ' PHE . 23.4 m -129.63 156.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.778 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.637 ' HG2' HG21 ' A' ' 238' ' ' ILE . 0.1 OUTLIER -82.84 104.88 13.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.187 0.518 . . . . 0.0 110.373 179.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.892 HD22 ' N ' ' A' ' 294' ' ' LEU . 0.0 OUTLIER -57.79 174.54 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.28 -178.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 1.088 HD12 HG21 ' A' ' 266' ' ' VAL . 0.0 OUTLIER -135.25 156.63 48.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.196 178.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 294' ' ' LEU . 1.3 m-20 164.3 -81.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.245 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.17 52.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.94 0.4 . . . . 0.0 110.847 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.81 114.13 24.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 301' ' ' GLU . 31.9 t-20 -128.07 126.16 23.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.67 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.74 -52.5 5.28 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.905 2.403 . . . . 0.0 112.796 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.92 23.12 6.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.459 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 298' ' ' ASN . 25.8 tt0 -46.65 -51.02 16.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.365 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.98 22.95 8.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.421 ' CD2' ' HB2' ' A' ' 304' ' ' SER . 43.0 p90 -52.79 -39.2 62.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.084 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' A' ' 303' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.961 179.987 . . . . . . . . 2 2 . 1 stop_ save_